• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hepatol Commun . Liver Injury in Hospitalized Patients with COVID-19 Correlates with Hyper Inflammatory Response and Elevated IL-6

tetano

Editor, Senior Moderator
Hepatol Commun


. 2020 Oct 16;10.1002/hep4.1631.
doi: 10.1002/hep4.1631. Online ahead of print.
Liver Injury in Hospitalized Patients with COVID-19 Correlates with Hyper Inflammatory Response and Elevated IL-6


Ben L Da[SUP] 1 [/SUP], Tatyana Kushner[SUP] 1 [/SUP], Maan El Halabi[SUP] 2 [/SUP], Pavan Paka[SUP] 2 [/SUP], Mian Khalid[SUP] 3 [/SUP], Angad Uberoi[SUP] 2 [/SUP], Brian T Lee[SUP] 1 [/SUP], Ponni V Perumalswami[SUP] 1 [/SUP], Stephanie M Rutledge[SUP] 4 [/SUP], Thomas D Schiano[SUP] 1 [/SUP], Scott Friedman[SUP] 1 [/SUP], Behnam Saberi[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Liver injury is commonly seen in coronavirus disease 2019 (COVID-19). However, the mechanism behind liver injury, particularly in severe and critical COVID-19 patients, remains unclear and the clinical course is poorly described.
Methods: We conducted a single-center, retrospective cohort study of consecutive hospitalized severe and critically ill COVID-19 patients with or without liver injury who underwent immunologic testing (IL-6, IL-8, TNF-α, and IL-1?). Liver injury was defined as peak aminotransferases ≥3x ULN (40 U/L) or ≥120 U/L. Patients with liver injury were compared to those who had normal aminotransferases throughout the hospital course.
Results: 176 patients were studied; 109 with liver injury and 67 controls. Patients with liver injury were more likely to be male (71.6% vs 37.3%; p < 0.001). Peak inflammatory markers and IL-6 were higher in the liver injury group: CRP: 247 vs 168 mg/L, p < 0.001; LDH: 706 vs 421 U/L, ferritin: 2,973 vs 751 ng/mL, p < 0.001, IL-6: 121.0 vs 71.8, p < 0.001. There was no difference in the levels of IL-8, TNF-α, and IL-1?. The liver injury group had a longer length of stay and more severe COVID-19 despite having less diabetes and chronic kidney disease.
Discussion: An exaggerated hyper inflammatory response (cytokine storm) characterized by significantly elevated CRP, LDH, ferritin, and IL-6 levels and increasing severity of COVID-19 appears to be associated with the occurrence of liver injury in patients with severe/ critical COVID-19.

Keywords: covid‐19; viral hepatitis; cytokine storm; inflammation; interleukin‐6.
 
Back
Top Bottom